{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:13:29Z","timestamp":1778512409554,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772255"],"award-info":[{"award-number":["81772255"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81501811"],"award-info":[{"award-number":["81501811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572060"],"award-info":[{"award-number":["81572060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.canlet.2020.04.010","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T02:03:38Z","timestamp":1586484218000},"page":"44-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Induction of CML-specific immune response through cross-presentation triggered by CTP-mediated BCR-ABL-derived peptides"],"prefix":"10.1016","volume":"482","author":[{"given":"Hao","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningshu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.canlet.2020.04.010_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"13","key":"10.1016\/j.canlet.2020.04.010_bib2","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"issue":"4946","key":"10.1016\/j.canlet.2020.04.010_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"247","author":"Lugo","year":"1990","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.canlet.2020.04.010_bib4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/s41409-019-0513-5","article-title":"Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry","volume":"54","author":"Lubking","year":"2019","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2014.08.010","article-title":"Structure, function, and resistance in chronic myeloid leukemia","volume":"26","author":"Radich","year":"2014","journal-title":"Canc. Cell"},{"issue":"6","key":"10.1016\/j.canlet.2020.04.010_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1078155217713363","article-title":"A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia","volume":"24","author":"DasGupta","year":"2018","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejso.2016.07.145","article-title":"Immunotherapy in melanoma: recent advances and future directions","volume":"43","author":"Franklin","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2020.04.010_bib8","first-page":"194","article-title":"Immunotherapy of cancer","volume":"46","author":"Trapani","year":"2017","journal-title":"Aust. Fam. Physician"},{"issue":"11","key":"10.1016\/j.canlet.2020.04.010_bib9","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.1158\/0008-5472.CAN-07-0302","article-title":"BCR-ABL activity is critical for the immunogenicity of chronic myelogenous leukemia cells","volume":"67","author":"Brauer","year":"2007","journal-title":"Canc. Res."},{"issue":"9","key":"10.1016\/j.canlet.2020.04.010_bib10","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood.V92.9.3362","article-title":"The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease","volume":"92","author":"Bose","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2020.04.010_bib11","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood-2003-01-0150","article-title":"Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation","volume":"102","author":"Rezvani","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2020.04.010_bib12","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2003-11-4086","article-title":"BCR-ABL-specific T cells can be detected in healthy donors and in chronic myeloid leukemia patients following allogeneic stem cell transplantation","volume":"103","author":"Butt","year":"2004","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.canlet.2020.04.010_bib13","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1182\/blood.V85.10.2680.bloodjournal85102680","article-title":"Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules","volume":"85","author":"Bocchia","year":"1995","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.canlet.2020.04.010_bib14","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/eji.1830270834","article-title":"Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes","volume":"27","author":"Buzyn","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.canlet.2020.04.010_bib15","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1182\/blood-2004-05-1915","article-title":"Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells","volume":"105","author":"Zeng","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2020.04.010_bib16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3389\/fimmu.2013.00496","article-title":"Dendritic cell-based immunotherapy for myeloid leukemias","volume":"4","author":"Schurch","year":"2013","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2020.04.010_bib17","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood.V87.9.3587.bloodjournal8793587","article-title":"Specific human cellular immunity to bcr-abl oncogene-derived peptides","volume":"87","author":"Bocchia","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.canlet.2020.04.010_bib18","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00262-011-1126-z","article-title":"Antigens in chronic myeloid leukemia: implications for vaccine development","volume":"60","author":"Smahel","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"19","key":"10.1016\/j.canlet.2020.04.010_bib19","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1182\/blood-2008-05-156471","article-title":"Defective homing and impaired induction of cytotoxic T cells by BCR\/ABL-expressing dendritic cells","volume":"113","author":"Mumprecht","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2020.04.010_bib20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-immunol-032713-120243","article-title":"Biology of CD1- and MR1-restricted T cells","volume":"32","author":"Salio","year":"2014","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib21","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.canlet.2020.04.010_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/eji.201445156","article-title":"Redirecting soluble antigen for MHC class I cross-presentation during phagocytosis","volume":"45","author":"Hari","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"9","key":"10.1016\/j.canlet.2020.04.010_bib23","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.4049\/jimmunol.1302850","article-title":"Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells","volume":"192","author":"Shen","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.immuni.2013.07.004","article-title":"Dendritic-cell-based therapeutic cancer vaccines","volume":"39","author":"Palucka","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.canlet.2020.04.010_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.yexcr.2005.12.029","article-title":"Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo","volume":"312","author":"Kim","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.canlet.2020.04.010_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pep.2009.06.019","article-title":"Cloning, expression, purification, distribution and kinetics characterization of the bacterial beta-galactosidase fused to the cytoplasmic transduction peptide in vitro and in vivo","volume":"68","author":"Huang","year":"2009","journal-title":"Protein Expr. Purif."},{"issue":"9","key":"10.1016\/j.canlet.2020.04.010_bib27","first-page":"40","article-title":"A method of improving the solubility of purified, concentrated and lyophilized polyvalent anti-snake venom serum by addition of glycine","volume":"55","author":"Devi","year":"1967","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/bp020077m","article-title":"Enhancement of monoclonal antibody production by lysine-containing peptides","volume":"19","author":"Franek","year":"2003","journal-title":"Biotechnol. Prog."},{"issue":"12","key":"10.1016\/j.canlet.2020.04.010_bib29","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.cellsig.2013.08.023","article-title":"Proteomic-based identification of Apg-2 as a therapeutic target for chronic myeloid leukemia","volume":"25","author":"Li","year":"2013","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopha.2011.02.013","article-title":"Purification of TAT-CC-HA protein under native condition, and its transduction analysis and biological effects on BCR-ABL positive cells","volume":"65","author":"Huang","year":"2011","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00000658-199707000-00002","article-title":"Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy","volume":"226","author":"Morse","year":"1997","journal-title":"Ann. Surg."},{"issue":"7","key":"10.1016\/j.canlet.2020.04.010_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s13238-010-0083-1","article-title":"RNF152, a novel lysosome localized E3 ligase with pro-apoptotic activities","volume":"1","author":"Zhang","year":"2010","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2012.11.017","article-title":"Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells","volume":"330","author":"Shao","year":"2013","journal-title":"Canc. Lett."},{"issue":"10","key":"10.1016\/j.canlet.2020.04.010_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri2173","article-title":"Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting","volume":"7","author":"Tacken","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"6673","key":"10.1016\/j.canlet.2020.04.010_bib35","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib36","doi-asserted-by":"crossref","first-page":"10046","DOI":"10.1038\/s41598-018-28106-5","article-title":"Development of a screening strategy for new modulators of T cell receptor signaling and T cell activation","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.canlet.2020.04.010_bib37","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4049\/jimmunol.173.4.2428","article-title":"The 4-1BB costimulation augments the proliferation of CD4+CD25+ regulatory T cells","volume":"173","author":"Zheng","year":"2004","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1182\/blood-2017-07-791608","article-title":"Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse","volume":"131","author":"Dossa","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2020.04.010_bib39","series-title":"Role of calprotectin as a modulator of the IL27-mediated proinflammatory effect on endothelial cells","first-page":"737310","volume":"2015","author":"Dorosz","year":"2015"},{"issue":"14","key":"10.1016\/j.canlet.2020.04.010_bib40","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.7150\/thno.24821","article-title":"Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma","volume":"8","author":"Hou","year":"2018","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.canlet.2020.04.010_bib41","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.7150\/thno.30577","article-title":"Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy","volume":"9","author":"Song","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib42","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41467-018-03900-x","article-title":"Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy","volume":"9","author":"Anker","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.canlet.2020.04.010_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13046-018-0732-4","article-title":"Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases","volume":"37","author":"Huang","year":"2018","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"7","key":"10.1016\/j.canlet.2020.04.010_bib44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41590-019-0399-9","article-title":"Adaptation and memory in immune responses","volume":"20","author":"Natoli","year":"2019","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2020.04.010_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nri.2016.13","article-title":"Immunological memory: lessons from the past and a look to the future","volume":"16","author":"Farber","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2020.04.010_bib46","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.canlet.2020.04.010_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11899-016-0309-2","article-title":"Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"11","author":"Caldemeyer","year":"2016","journal-title":"Curr. Hematol. Malig. Rep."},{"issue":"6345","key":"10.1016\/j.canlet.2020.04.010_bib48","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/353622a0","article-title":"Sequence analysis of peptides bound to MHC class II molecules","volume":"353","author":"Rudensky","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.04.010_bib49","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.iy.12.040194.001145","article-title":"Structure of peptides associated with class I and class II MHC molecules","volume":"12","author":"Engelhard","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.canlet.2020.04.010_bib50","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S1470-2045(13)70585-0","article-title":"Clinical use of dendritic cells for cancer therapy","volume":"15","author":"Anguille","year":"2014","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2020.04.010_bib51","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.4049\/jimmunol.180.11.7687","article-title":"No advantage of cell-penetrating peptides over receptor-specific antibodies in targeting antigen to human dendritic cells for cross-presentation","volume":"180","author":"Tacken","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib52","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2174\/138920309788452191","article-title":"Predicting affinity and specificity of antigenic peptide binding to major histocompatibility class I molecules","volume":"10","author":"Sieker","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib53","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1158\/0008-5472.CAN-18-1078","article-title":"CML hematopoietic stem cells expressing IL1RAP can Be targeted by chimeric antigen receptor-engineered T cells","volume":"79","author":"Warda","year":"2019","journal-title":"Canc. Res."},{"issue":"8","key":"10.1016\/j.canlet.2020.04.010_bib54","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/07357907.2018.1515315","article-title":"Natural killer cell-based cancer immunotherapy: a review on 10 Years completed clinical trials","volume":"36","author":"Suen","year":"2018","journal-title":"Canc. Invest."},{"issue":"3","key":"10.1016\/j.canlet.2020.04.010_bib55","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.leukres.2010.05.028","article-title":"BCR-ABL peptide vaccination in healthy subjects: immunological responses are equivalent to those in chronic myeloid leukaemia patients","volume":"35","author":"Rojas","year":"2011","journal-title":"Leuk. Res."},{"issue":"4","key":"10.1016\/j.canlet.2020.04.010_bib56","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1586\/1744666X.2015.1019474","article-title":"Immunology of chronic myeloid leukemia: current concepts and future goals","volume":"11","author":"Vonka","year":"2015","journal-title":"Expet Rev. Clin. Immunol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520301877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520301877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:49:13Z","timestamp":1778510953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520301877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":56,"alternative-id":["S0304383520301877"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.04.010","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of CML-specific immune response through cross-presentation triggered by CTP-mediated BCR-ABL-derived peptides","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}